U.S. Markets closed

Perrigo Company plc (PRGO)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
71.36+0.57 (+0.81%)
At close: 4:02PM EDT

68.75 -2.61 (-3.66%)
After hours: 7:57PM EDT

People also watch
MYLENDPALXNTEVAREGN
Interactive chart
Previous Close70.79
Open70.80
Bid0.00 x
Ask0.00 x
Day's Range70.33 - 71.79
52 Week Range65.47 - 111.00
Volume1,198,096
Avg. Volume2,043,146
Market Cap10.23B
Beta0.62
PE Ratio (TTM)926.75
EPS (TTM)0.08
Earnings DateMay 25, 2017
Dividend & Yield0.64 (0.90%)
Ex-Dividend Date2017-03-01
1y Target Est79.62
Trade prices are not sourced from all markets
  • Associated Press2 hours ago

    Perrigo reports 4Q loss

    On a per-share basis, the Dublin-based company said it had a loss of $9.48. Earnings, adjusted for non-recurring costs and asset impairment costs, came to $1.24 per share. The drug company posted revenue ...

  • Perrigo to Conduct Conference Call on May 23, 2017 at 8:30 AM ET
    PR Newswire3 hours ago

    Perrigo to Conduct Conference Call on May 23, 2017 at 8:30 AM ET

    TASE: PRGO) today announced that it will conduct a conference call on Tuesday, May 23 at 8:30AM (ET) hosted by John T. Hendrickson, Perrigo's Chief Executive Officer, to discuss the Company's fourth quarter and calendar year 2016 results and its financial statements. Perrigo Company plc, a leading global healthcare company, delivers value to its customers and consumers by providing Quality Affordable Healthcare Products®. Founded in 1887 as a packager of home remedies, Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network.

  • Market Realist12 hours ago

    Incyte Was the S&P 500’s Top Gainer on May 18

    Incyte rose to one-month high price levels on May 18. Incyte opened higher on Thursday due to positive results from its lung cancer drug.